EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exogenous Ketone Supplementation Enhances the Anti-Epileptic Effect of Levetiracetam in Wistar Albino Glaxo/Rijswijk Rats

Enikő Rauch iD, Csilla Ari iD, Dominic P D'Agostino iD, Zsolt Kovács iD

Nutrients · 2025

DOI: 10.3390/nu17101721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Enikő Rauch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Berzsenyi Dániel Teacher Training Centre, ELTE Eötvös Loránd University, Károlyi Gáspár tér 4, 9700 Szombathely, Hungary. Hauptthemen laut MEDLINE: Levetiracetam, Anticonvulsants, Dietary Supplements, Ketones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ELTE BDPK Excellence Program, Ketone Technologies, Ketone Technologies LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It has been demonstrated that levetiracetam can decrease absence epileptic activity in both human patients and different types of animal models of absence epilepsy, such as the genetically absence epileptic Wistar Albino Glaxo/Rijswijk (WAG/Rij) rat. It was also suggested previously that exogenous ketone supplements (EKSs)-evoked ketosis not only decreases the number of spike-wave discharges (SWDs) but also enhances the anti-absence epileptic effect of pyrimidine nucleoside uridine in WAG/Rij rats. These findings suggest that EKSs may enhance the efficacy of clinically used anti-epileptic drugs, such as levetiracetam.

Methods

We investigated the effect of not only levetiracetam (intraperitoneal/i.p. 200 mg/kg) alone and KEKS supplemented food (containing 10% ketone ester/KE and 10% ketone salt/KS in a normal rat chow) alone, but also the combination of levetiracetam and KEKS supplemented food on SWD number and SWD time for 5 days in WAG/Rij rats. For evaluation of SWDs, electroencephalographic (EEG) recordings were performed every day. Moreover, for the measurement of blood glucose and R-beta-hydroxybutyrate (R-βHB) levels, the blood was taken from the tail vein of rats after EEG registration.

Results

It was demonstrated that the administration of both levetiracetam alone and KEKS food alone decreased the SWD number and time spent in SWD, compared to control. Moreover, after combined administration of levetiracetam with KEKS food, enhanced anti-absence epileptic effect was observed, compared to levetiracetam alone. Blood R-βHB level significantly increased after administration of both KEKS food alone and KEKS food in combination with levetiracetam. Nevertheless, these treatments did not significantly change the blood glucose levels.

Conclusions

We can conclude that EKSs may be able to enhance the anti-epileptic effect of different drugs, and this combined treatment method may represent a promising new approach and effective therapy against epileptic seizures, especially in treatment-resistant patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevetiracetamAnticonvulsantsDietary SupplementsKetonesEpilepsy, AbsenceAnimalsRats, WistarRatsElectroencephalographyMaleDisease Models, AnimalBlood Glucose3-Hydroxybutyric AcidKetosis

Stichwörter der Autor:innen

WAG/Rij ratepilepsyketone supplementlevetiracetam

Substanzen

LevetiracetamAnticonvulsantsKetonesBlood Glucose3-Hydroxybutyric Acid

Autor:innen und Institutionen

  • Department of Biology, Berzsenyi Dániel Teacher Training Centre, ELTE Eötvös Loránd University, Károlyi Gáspár tér 4, 9700 Szombathely, Hungary.
  • Institute of Biology, University of Pécs, Ifjúság Str. 6, 7624 Pécs, Hungary.
  • Ketone Technologies LLC, Tampa, FL 33612, USA.
  • Behavioral Neuroscience Research Laboratory, Department of Psychology, University of South Florida, Tampa, FL 33620, USA.
  • Laboratory of Metabolic Medicine, Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
  • Institute for Human and Machine Cognition, Ocala, FL 34471, USA.

ORCID-Profile: Enikő Rauch, Csilla Ari, Dominic P D'Agostino, Zsolt Kovács

Förderung

  • ELTE BDPK Excellence Program
  • Ketone Technologies
  • Ketone Technologies LLC

Zitieren

APA

Rauch, E., Ari, C., D'Agostino, D. P., & Kovács, Z. (2025). Exogenous Ketone Supplementation Enhances the Anti-Epileptic Effect of Levetiracetam in Wistar Albino Glaxo/Rijswijk Rats. Nutrients. https://doi.org/10.3390/nu17101721

Vancouver

Rauch E, Ari C, D'Agostino DP, Kovács Z. Exogenous Ketone Supplementation Enhances the Anti-Epileptic Effect of Levetiracetam in Wistar Albino Glaxo/Rijswijk Rats. Nutrients. 2025. doi:10.3390/nu17101721

BibTeX
@article{Rauch2025,
  author = {Rauch, Enikő and Ari, Csilla and D'Agostino, Dominic P and Kovács, Zsolt},
  title = {Exogenous Ketone Supplementation Enhances the Anti-Epileptic Effect of Levetiracetam in Wistar Albino Glaxo/Rijswijk Rats},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17101721}
}
Kostenlos starten →